查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618776

寡核苷酸合成市場：按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年寡核苷酸合成市場價值為102.9億美元，預計2024年將達到122.4億美元，複合年成長率為20.24%，到2030年將達到374.1億美元。

寡核苷酸合成涉及短核苷酸序列的化學合成，短核苷酸序列是 DNA 和 RNA 的組成部分。這個過程對於各種研究和治療應用至關重要，包括藥物開發、基因檢測和分子診斷。對個人化醫療的日益重視、生物技術的進步以及遺傳疾病的日益流行推動了對合成寡核苷酸的需求。典型的最終用戶包括製藥公司、生技公司、學術機構和研究機構。對創新基因療法的迫切需求以及基因組學和蛋白​​質組學等領域的進步為市場提供了支持。該領域的成長是由合成技術的技術進步、研究活動的擴大以及基因組學計劃資金的增加等因素所推動的。然而，高合成成本、複雜的監管環境以及大規模生產的技術困難等挑戰帶來了限制。開發具有成本效益的高通量合成平台並提高寡核苷酸藥物的精確度和效率的機會比比皆是。將奈米級寡核苷酸合成與人工智慧結合進行預測分析帶來了重大的創新機會。儘管競爭非常激烈，但策略夥伴關係和聯盟對於市場滲透和擴張至關重要。此外，專注於永續製造技術並整合環保方法可以提供競爭優勢。市場相關人員還必須密切注意不斷變化的法規環境，以降低合規相關風險。潛在的成長領域包括罕見疾病和感染疾病等新的治療領域。鼓勵開放創新並促進與學術和研究機構的合作可以鼓勵新的發現和應用，並幫助企業保持領先地位。總之，市場格局充滿機遇，但相關人員必須巧妙應對隨之而來的挑戰，以最大限度地發揮其持續業務成長的潛力。

主要市場統計
基準年[2023] 102.9億美元
預計年份 [2024] 122.4億美元
預測年份 [2030] 374.1億美元
複合年成長率（%） 20.24%

市場動態：揭示快速發展的寡核苷酸合成市場的關鍵市場洞察

寡核苷酸合成市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病流行和對藥物發現的興趣日益濃厚
    • 合成寡核苷酸在分子診斷和臨床應用的使用越來越多
    • 對製藥和生物技術研究的大量投資
  • 市場限制因素
    • 寡核苷酸生產成本高
  • 市場機會
    • 寡核苷酸合成的改進與進步
    • 策略聯盟以增加寡核苷酸產量
  • 市場挑戰
    • 與大規模寡核苷酸合成相關的併發症

波特的五力：駕馭寡核苷酸合成市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解寡核苷酸合成市場的外部影響

外部宏觀環境因素在塑造寡核苷酸合成市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解寡核苷酸合成市場的競爭狀況

對寡核苷酸合成市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣寡核苷酸合成市場供應商績效評估

FPNV定位矩陣是評估寡核苷酸合成市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製寡核苷酸合成市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，寡核苷酸合成市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 更關注慢性病的傳播與新藥發現
      • 合成寡核苷酸在分子診斷和臨床應用的使用越來越多
      • 對製藥和生物技術研究的大量投資
    • 抑制因素
      • 寡核苷酸生產高成本
    • 機會
      • 寡核苷酸合成的改進與進步
      • 策略聯盟增加寡核苷酸產量
    • 任務
      • 與大規模寡核苷酸合成相關的併發症
  • 市場區隔分析
    • 產品：增加使用合成寡核苷酸來支持研究和治療設計
    • 最終用戶：寡核苷酸合成對於學術研究機構新科學技術發展的巨大潛力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章寡核苷酸合成市場：依產品

  • 裝置
  • 連接子和適配器
  • 探測
  • 試劑/耗材
  • 服務
  • 合成寡核苷酸

第7章寡核苷酸合成市場：依類型

  • 自訂
  • 預先設計的

第8章寡核苷酸合成市場：依應用分類

  • 診斷
  • 調查
  • 治療性的

第9章寡核苷酸合成市場：依最終用戶分類

  • 學術研究所
  • 合約研究官（CRO）和首席行銷長（CMO）
  • 診斷實驗室和醫院
  • 製藥和生物技術公司

第10章美洲寡核苷酸合成市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太寡核苷酸合成市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲寡核苷酸合成市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Codexis 推出生態合成平台以增強寡核苷酸生產
    • Corden Pharma 在科羅拉多進行策略性擴張，提高寡核苷酸產量
    • Oligo Factory 開設先進的寡核苷酸生產設施
    • 英國創新合作旨在改變寡核苷酸生產
    • 安捷倫科技擴大寡核苷酸產能
    • Aurisco 和 Cytiva推出中國首款 Oligo FlexFactory
    • 無錫 STA 在中國開設新的寡核苷酸和胜肽生產設施
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Ajinomoto Bio-Pharma Services
  • ATDBio Ltd.
  • Bio-synthesis Inc.
  • Biocomma Ltd.
  • Biolegio BV
  • Biolytic Lab Performance Inc.
  • Bioserve India by Reprocell Group
  • Bon Opus Biosciences, LLC
  • Creative Biogene
  • Cusabio Technology LLC
  • Danaher Corporation
  • Eurofins Genomics LLC
  • Eurogentec SA by Kaneka Corporation
  • GE Healthcare Inc.
  • Generi Biotech
  • Genscript Corporation
  • Hongene Biotech Corp.
  • LGC Genomics Limited
  • Merck KGaA
  • Microsynth AG
  • Nitto Denko Avecia Inc.
  • Novartis AG
  • PerkinElmer, Inc.
  • Synbio Technologies
  • TAG Copenhagen A/S
  • TCI Chemicals（India）Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.
Product Code: MRR-0A609A26A918

The Oligonucleotide Synthesis Market was valued at USD 10.29 billion in 2023, expected to reach USD 12.24 billion in 2024, and is projected to grow at a CAGR of 20.24%, to USD 37.41 billion by 2030.

Oligonucleotide synthesis involves the chemical synthesis of short sequences of nucleotides, which are the building blocks of DNA and RNA. This process is essential for various research and therapeutic applications, including drug development, genetic testing, and molecular diagnostics. The demand for synthesized oligonucleotides is propelled by the growing emphasis on personalized medicine, advances in biotechnology, and the increasing prevalence of genetic disorders. Key end-users include pharmaceuticals, biotechnology companies, academic institutes, and research organizations. The market is buoyed by the urgent need for innovative genetic therapies and advancements in fields like genomics and proteomics. Growth in this sector is driven by factors such as technological advancements in synthesis techniques, the expansion of research activities, and increased funding for genomics projects. However, challenges such as high costs of synthesis, complex regulatory landscapes, and technical difficulties in large-scale production pose limitations. Opportunities abound in developing cost-effective, high-throughput synthesis platforms and enhancing the accuracy and efficiency of oligonucleotide drugs. Nanoscale oligonucleotide synthesis and integration with AI for predictive analytics present significant innovation opportunities. Despite intense competition, strategic partnerships and collaborations are indispensable for market penetration and expansion. Additionally, focusing on sustainable manufacturing technologies and integrating eco-friendly approaches could yield competitive advantages. Market players should also keep an eye on the evolving regulatory environment to mitigate compliance-related risks. Potential growth areas include novel therapeutic areas such as rare diseases and infectious diseases. Encouraging open innovation and fostering collaborations with academic and research institutions can spur novel discoveries and applications, helping companies stay at the forefront. In summary, while the oligonucleotide synthesis market presents a landscape ripe with opportunities, stakeholders must navigate the accompanying challenges adeptly to harness its full potential for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 10.29 billion
Estimated Year [2024] USD 12.24 billion
Forecast Year [2030] USD 37.41 billion
CAGR (%) 20.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oligonucleotide Synthesis Market

The Oligonucleotide Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and growing focus on drug discovery
    • Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
    • Significant investments in pharmaceutical and biotechnology research
  • Market Restraints
    • High cost of oligonucleotides production
  • Market Opportunities
    • Improvements and advances in oligonucleotide synthesis
    • Strategic alliances for increasing production of oligonucleotides
  • Market Challenges
    • Complications associated with large scale oligonucleotide synthesis

Porter's Five Forces: A Strategic Tool for Navigating the Oligonucleotide Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oligonucleotide Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oligonucleotide Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oligonucleotide Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oligonucleotide Synthesis Market

A detailed market share analysis in the Oligonucleotide Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oligonucleotide Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oligonucleotide Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oligonucleotide Synthesis Market

A strategic analysis of the Oligonucleotide Synthesis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oligonucleotide Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ajinomoto Bio-Pharma Services, ATDBio Ltd., Bio-synthesis Inc., Biocomma Ltd., Biolegio B.V., Biolytic Lab Performance Inc., Bioserve India by Reprocell Group, Bon Opus Biosciences, LLC, Creative Biogene, Cusabio Technology LLC, Danaher Corporation, Eurofins Genomics LLC, Eurogentec S.A. by Kaneka Corporation, GE Healthcare Inc., Generi Biotech, Genscript Corporation, Hongene Biotech Corp., LGC Genomics Limited, Merck KGaA, Microsynth AG, Nitto Denko Avecia Inc., Novartis AG, PerkinElmer, Inc., Synbio Technologies, TAG Copenhagen A/S, TCI Chemicals (India) Pvt. Ltd., Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Oligonucleotide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Equipment, Linkers & Adaptor, Probes, Reagents & Consumables, Services, and Synthesized Oligonucleotides.
  • Based on Type, market is studied across Custom and Pre-designed.
  • Based on Application, market is studied across Diagnostic, Research, and Therapeutic.
  • Based on End-User, market is studied across Academic Research Institutes, CROs & CMOs, Diagnostic Laboratories & Hospitals, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and growing focus on drug discovery
      • 5.1.1.2. Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 5.1.1.3. Significant investments in pharmaceutical and biotechnology research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of oligonucleotides production
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements and advances in oligonucleotide synthesis
      • 5.1.3.2. Strategic alliances for increasing production of oligonucleotides
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with large scale oligonucleotide synthesis
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of synthesized oligonucleotides for aiding research and treatment design
    • 5.2.2. End-User: High potential of oligonucleotide synthesis among academic research institutes for developing new scientific techniques
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oligonucleotide Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
  • 6.3. Linkers & Adaptor
  • 6.4. Probes
  • 6.5. Reagents & Consumables
  • 6.6. Services
  • 6.7. Synthesized Oligonucleotides

7. Oligonucleotide Synthesis Market, by Type

  • 7.1. Introduction
  • 7.2. Custom
  • 7.3. Pre-designed

8. Oligonucleotide Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Research
  • 8.4. Therapeutic

9. Oligonucleotide Synthesis Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. CROs & CMOs
  • 9.4. Diagnostic Laboratories & Hospitals
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Oligonucleotide Synthesis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Oligonucleotide Synthesis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Oligonucleotide Synthesis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Codexis Introduces Eco Synthesis Platform for Enhanced Oligonucleotide Manufacturing
    • 13.3.2. CordenPharma Enhances Oligonucleotide Production with Strategic Expansion in Colorado
    • 13.3.3. Oligo Factory Launches Advanced Oligonucleotide Production Facility
    • 13.3.4. UK's Innovative Collaboration Aims to Transform Oligonucleotide Production
    • 13.3.5. Agilent Technologies Expands Oligonucleotide Production Capacity
    • 13.3.6. Aurisco and Cytiva Launch China's First Oligo FlexFactory
    • 13.3.7. Wuxi STA Expands with New Oligonucleotide and Peptide Production Facility in China
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Ajinomoto Bio-Pharma Services
  • 3. ATDBio Ltd.
  • 4. Bio-synthesis Inc.
  • 5. Biocomma Ltd.
  • 6. Biolegio B.V.
  • 7. Biolytic Lab Performance Inc.
  • 8. Bioserve India by Reprocell Group
  • 9. Bon Opus Biosciences, LLC
  • 10. Creative Biogene
  • 11. Cusabio Technology LLC
  • 12. Danaher Corporation
  • 13. Eurofins Genomics LLC
  • 14. Eurogentec S.A. by Kaneka Corporation
  • 15. GE Healthcare Inc.
  • 16. Generi Biotech
  • 17. Genscript Corporation
  • 18. Hongene Biotech Corp.
  • 19. LGC Genomics Limited
  • 20. Merck KGaA
  • 21. Microsynth AG
  • 22. Nitto Denko Avecia Inc.
  • 23. Novartis AG
  • 24. PerkinElmer, Inc.
  • 25. Synbio Technologies
  • 26. TAG Copenhagen A/S
  • 27. TCI Chemicals (India) Pvt. Ltd.
  • 28. Thermo Fisher Scientific Inc.
  • 29. TriLink BioTechnologies, Inc.

LIST OF FIGURES

  • FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023